News

Article

AJMC® in the Press, March 29, 2024

Author(s):

AJMC Staff

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

An article from Drug Topics referenced an article published on AJMC.com, the website of The American Journal of Managed Care®. The article, “Bempedoic Acid, Approved to Treat LDL Cholesterol, Cuts Risk of Major CV Events by 13%,” highlighted findings from the CLEAR Outcomes trial that were presented at the 72nd American College of Cardiology Scientific Sessions together with the World Congress of Cardiology.

Related Videos
Edgardo S. Santos, MD, FACP, FASCO
Firas El Chaer, MD, smiling during a video interview
Firas El Chaer, MD, smiling during a video interview
1 expert is featured in this series.
Related Content
Mehrdad Mobasher, MD, MPH | Image credit: BeiGene
January 2nd 2025

BeiGene’s Mehrdad Mobasher, MD, MPH, Discusses CLL Data, Pipeline Following ASH 2024

Mary Caffrey
This interview will appear in the January 2025 issue of Evidence-Based Oncology, our annual recap of the American Society of Hematology Meeting and Exposition. After this article went to press, the company announced its ticker symbol on the Nasdaq will change today.
AJMC Managed Care Cast
December 31st 2024

AJMC® Editors Reflect on 2024 and Look Forward to a Milestone

Christina Mattina
The editors in chief of The American Journal of Managed Care® discuss the key managed care research and news from 2024 and look forward to the journal’s upcoming 30th anniversary.
Jennifer Vaughn, MD, smiling during a zoom interview
January 1st 2025

Personalizing MPN Disease Management and Monitoring

Laura Joszt, MA
The individual behavior of a patient’s myeloproliferative neoplasm (MPN) will determine how the disease is monitored and managed in the long term, explained Jennifer Vaughn, MD, of The Ohio State University Comprehensive Cancer Center.
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024

Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL

A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Top 5 Most-Read HIV Articles of 2024
January 1st 2025

Top 5 Most-Read HIV Articles of 2024

Julia Bonavitacola
Top articles about HIV this year included effects of HIV on tooth loss and cardiac surgery, caregiver experiences, and a federal ruling on military enlistment.
Ryan Nguyen, DO
January 1st 2025

AI in Oncology: Opportunities and Challenges for NSCLC

Skylar Jeremias
Ryan Nguyen, DO, University of Illinois Chicago, highlights the importance of personalized care for patients who have non–small cell lung cancer (NSCLC) and the potential of artificial intelligence (AI) in oncology, while cautioning against its limitations, including the risk of unsupported recommendations.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo